Avience Biomedicals IPO Review 2026: Price Band, GMP, Listing Dates, Financials & Analysis
Avience Biomedicals IPO is a Book Built Issue aggregating up to ₹30.24 crore. The IPO comprises a fresh issue of 14,53,800 equity shares. The company proposes to list its shares on the NSE SME platform.
| Particulars | Details |
|---|---|
| IPO Opening Date | June 18, 2026 |
| IPO Closing Date | June 22, 2026 |
| Issue Type | Book Built Issue |
| Issue Size | ₹30.24 Crore |
| Fresh Issue | 14,53,800 Shares |
| Price Band | ₹196 to ₹208 per Share |
| Face Value | ₹10 per Share |
| Lot Size | 600 Shares |
| Listing Exchange | NSE SME |
| Market Cap (Pre-Issue) | ₹114.09 Crore |
Avience Biomedicals IPO Important Dates
| Event | Date |
|---|---|
| IPO Opens | June 18, 2026 |
| IPO Closes | June 22, 2026 |
| Basis of Allotment | June 23, 2026 |
| Refund Initiation | June 24, 2026 |
| Credit of Shares | June 24, 2026 |
| Listing Date | June 25, 2026 |
Refer to RHP for detailed information.
About Avience Biomedicals Limited
Incorporated in June 2024, Avience Biomedicals Limited is an ISO-certified company engaged in manufacturing, supplying, exporting, and distributing molecular diagnostic solutions focused on biotechnology, genomics, and the in-vitro diagnostics (IVD) industry.
The company initially started with rapid test kits and later expanded its product portfolio to include serology products, molecular diagnostics, biochemistry analyzers, hematology analyzers, and medical devices catering to pathology labs, hospitals, microbiology labs, and research centers.
Avience Biomedicals operates primarily in the B2B and B2G segments and also acts as a distributor and trader of medical equipment and healthcare diagnostic devices.
The company’s manufacturing facility is located in Noida, Uttar Pradesh. As of January 31, 2026, the company had 75 permanent employees and 33 contractual employees.
Product Portfolio
- Rapid Test Kits
- Molecular Diagnostic Kits
- COVID-19 RT-qPCR Detection Kits
- Biochemistry Analyzers
- Biochemistry Reagents
- Hematology Analyzers
- Oxygen Concentrators
- Medical Devices
- Viral Transport Media (VTM)
- Diagnostic Laboratory Consumables
Competitive Strengths
- Strong experience and expertise in diagnostics and biotechnology.
- Diversified product portfolio across molecular diagnostics and IVD products.
- Pan-India distribution network with growing international presence.
- Focus on affordable and cost-effective diagnostic solutions.
- ISO-certified manufacturing and quality control standards.
- Established relationships with hospitals, labs, and research centers.
- Presence across B2B and B2G healthcare markets.
Avience Biomedicals IPO Reservation Details
| Category | Shares Offered |
|---|---|
| Market Maker Reservation | 82,200 Shares |
| Net Public Offer | 13,71,600 Shares |
| Total Issue Size | 14,53,800 Shares |
Shareholding Pattern
| Particulars | No. of Shares |
|---|---|
| Pre-Issue Shareholding | 40,31,256 |
| Post-Issue Shareholding | 54,85,056 |
Lead Manager
- Book Running Lead Manager: Fintellectual Corporate Advisors Private Limited
- Market Maker: Asnani Stock Broker Private Limited
Objects of the Issue
The company intends to utilize the net proceeds from the IPO towards business expansion, working capital requirements, strengthening manufacturing capabilities, and general corporate purposes as specified in the Red Herring Prospectus (RHP).
IPO Allotment & Application Status
Registrar: Skyline Financial Services Private Limited
Empower your IPO investment journey — stay informed with accurate dates, price band and filings.
Track Live & Upcoming IPOs
Frequently Asked Questions (FAQs) - Avience Biomedicals IPO
What is the Avience Biomedicals IPO date?
Avience Biomedicals IPO opens on June 18, 2026 and closes on June 22, 2026.
What is the price band of Avience Biomedicals IPO?
The IPO price band is fixed at ₹196 to ₹208 per equity share.
What is the lot size of Avience Biomedicals IPO?
The minimum lot size for the IPO application is 600 shares.
How much investment is required for Avience Biomedicals IPO?
Retail investors are required to invest a minimum of ₹2,49,600 for 1,200 shares at the upper price band.
What does Avience Biomedicals Limited do?
Avience Biomedicals manufactures and supplies molecular diagnostic kits, rapid test kits, analyzers, medical devices, and healthcare diagnostic solutions for laboratories, hospitals, and research centers.
Where will Avience Biomedicals IPO be listed?
The shares are proposed to be listed on the NSE SME platform.
Who is the registrar of Avience Biomedicals IPO?
Skyline Financial Services Private Limited is the registrar to the issue.
What is the issue size of Avience Biomedicals IPO?
The IPO issue size is ₹30.24 crore consisting entirely of a fresh issue.
Where is the manufacturing facility of Avience Biomedicals located?
The company’s manufacturing facility is located in Noida, Uttar Pradesh.
Which industries does Avience Biomedicals cater to?
The company serves pathology labs, microbiology labs, hospitals, healthcare institutions, and research centers across India and overseas markets.
Investor Education Hub: Everything You Need to Know About IPOs
- How to Analyse an IPO Before Applying
- Step-by-Step Guide: IPO Process in India
- Understanding IPO Application & Allotment (UPI / ASBA & Eligibility)
- 8 Tips to Improve Your Chances of IPO Allotment
Disclaimer: - Investments in IPOs are subject to market risks. Investors should read the Red Herring Prospectus carefully and consult their financial advisor before investing. https://www.mnclgroup.com/research-disclaimer
